Gilead's $2 Billion Buyout of Ouro Medicines Expands Biotech Reach

Gilead's $2 Billion Buyout of Ouro Medicines Expands Biotech Reach

The Deal's Core Details Gilead revealed its plan to acquire Ouro Medicines for a sum exceeding $2 billion. The buyout positions Ouro's assets to integ...